-
Published29/09/2023
-
Deadline10/11/2024
-
Opening of tenders10/11/2024
-
Today07/08/2026
Utilities
- indicates text translated automatically in your browsing language
Germany-Düsseldorf: Pharmaceutical products
Paragraph 130a(8) of the SGB V enables health insurance funds (KK) and pharmaceutical companies to conclude framework discount agreements for the medicinal products to be supplied at the expense of the statutory health insurance companies. GWQ acts as a company for cost-effectiveness and quality at KK in accordance with § 130a(8)(5) SGBV for its shareholder and customer funds. With regard to the relevant statutory provisions on public procurement, a regular process of active substance-related, formal procurement procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until the entry into force of new drug discount agreements, GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies. Contract start date is 01.11.2023
Official name: GWQ ServicePlus AG
Postal address: GWQ ServicePlus AG, Ria-Thiele-Straße 2a, 40549 Düsseldorf, handelnd für die unter VI 3.) näher genannten Gesetzlichen Krankenkassen
Town: Düsseldorf
NUTS code: DE
Country: DEU
Main address: http://www.gwq-serviceplus.de
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.